Variant position: 413 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 595 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human EEAKLLAQKAAEAEQEMQRI KATAIRTEEEKRLMEQKVLEA
Mouse EEAKLLAQKAAEAEQEMQRI KATAIRTEEEKRLMEQKVLEA
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 595 Merlin
327 – 465 Glu-rich
150 – 579 Missing. In isoform 9.
260 – 595 Missing. In isoform 7.
380 – 595 Missing. In isoform 10.
Eleven novel mutations in the NF2 tumour suppressor gene.
Bourn D.; Evans G.; Mason S.; Tekes S.; Trueman L.; Strachan T.;
Hum. Genet. 95:572-574(1995)
Cited for: VARIANTS NF2 PHE-119 DEL; GLU-413 AND PRO-535;
Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations.
Evans D.G.R.; Trueman L.; Wallace A.; Collins S.; Strachan T.;
J. Med. Genet. 35:450-455(1998)
Cited for: VARIANTS NF2 SER-62; VAL-77; GLY-106; MET-352; GLU-413 AND PRO-535;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.